These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23721191)

  • 1. Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography.
    Dobashi A; Imazu H; Tatsumi N; Okabe M; Ang TL; Tajiri H
    Scand J Gastroenterol; 2013 Jul; 48(7):848-55. PubMed ID: 23721191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
    Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
    Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma.
    Hamada S; Satoh K; Hirota M; Kanno A; Ishida K; Umino J; Ito H; Kikuta K; Kume K; Masamune A; Katayose Y; Unno M; Shimosegawa T
    Cancer Sci; 2011 Jan; 102(1):150-6. PubMed ID: 21029254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic cytology in biliary strictures. Personal experience.
    Geraci G; Pisello F; Arnone E; Modica G; Sciumè C
    G Chir; 2008 Oct; 29(10):403-6. PubMed ID: 18947461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
    Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
    Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results.
    DeWitt J; Misra VL; Leblanc JK; McHenry L; Sherman S
    Gastrointest Endosc; 2006 Sep; 64(3):325-33. PubMed ID: 16923477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma.
    Kawashima H; Itoh A; Ohno E; Miyahara R; Ohmiya N; Tanaka T; Shimoyama Y; Nakamura S; Ebata T; Nagino M; Goto H; Hirooka Y
    J Hepatobiliary Pancreat Sci; 2013 Apr; 20(4):441-7. PubMed ID: 23269460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of WWOX expression in human extrahepatic cholangiocarcinoma.
    Wang M; Gu J; Wang Y; Gong B
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):39-44. PubMed ID: 18629536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of extrahepatic cholangiocarcinoma: results in a series of 124 patients.
    Albu S; Tantau M; Sparchez Z; Branda H; Suteu T; Badea R; Pascu O
    Rom J Gastroenterol; 2005 Mar; 14(1):33-6. PubMed ID: 15800691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation Markers Improve the Sensitivity of Endoscopic Retrograde Cholangiopancreatography-Based Brushing Cytology in Extrahepatic Cholangiocarcinoma.
    Prachayakul V; Kanchanapermpoon J; Thuwajit C; Boonyaarunnate T; Pongpaibul A; Chobson P; Thuwajit P
    Technol Cancer Res Treat; 2017 Dec; 16(6):1252-1258. PubMed ID: 29484968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic bile duct carcinoma: US characteristics and accuracy in demonstration of tumors.
    Robledo R; Muro A; Prieto ML
    Radiology; 1996 Mar; 198(3):869-73. PubMed ID: 8628885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of MSX2 mRNA expression level in biliary brush cytological specimens.
    Ito H; Satoh K; Hamada S; Hirota M; Kanno A; Ishida K; Unno J; Masamune A; Katayose Y; Unno M; Shimosegawa T
    Anticancer Res; 2011 Mar; 31(3):1011-7. PubMed ID: 21498730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography.
    Glasbrenner B; Ardan M; Boeck W; Preclik G; Möller P; Adler G
    Endoscopy; 1999 Nov; 31(9):712-7. PubMed ID: 10604612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography.
    Lee MG; Lee HJ; Kim MH; Kang EM; Kim YH; Lee SG; Kim PN; Ha HK; Auh YH
    Radiology; 1997 Mar; 202(3):663-9. PubMed ID: 9051013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
    Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G
    Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.